Skip to main content

Repligen

Repligen Corp is an American bioprocessing technology provider manufacturing specialized equipment and consumables for biological drug manufacturing. The company produces protein A affinity ligands, cell retention systems, chromatography columns, filtration systems, and fluid management products under brands like XCell and KrosFlo. Revenue is principally derived from direct product sales of bioprocessing hardware and single-use consumables to biopharmaceutical companies and contract manufacturers. Core end markets encompass biotechnology firms, global pharmaceutical corporations, and contract development manufacturing organizations worldwide. Repligen holds a market-leading position in bioprocessing filtration, chromatography, and cell retention tools supporting biologic drug production. The corporation is headquartered in Waltham, Massachusetts, and its common stock trades on the Nasdaq Global Select Market.

16 of the funds FundTelligence covers report a position in Repligen.

Legal name
Repligen Corp
Sector
Health Care
Country
United States
Funds holding it
16

Funds holding Repligen

Showing the 8 largest of 16 funds holding it.

Loading...